Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Overview

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) General Information

Description

A portfolio of royalties on future sales of approved drugs. The portfolio consists of rights to receive royalties on the future sales of pharmaceutical drugs under the brand names Movantik, Adynovate, and Rebinyn.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • San Francisco, CA
  • United States
Primary Industry
Buildings and Property
Corporate Office
  • San Francisco, CA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)‘s full profile, request access.

Request a free trial

Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)‘s full profile, request access.

Request a free trial

Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) FAQs

  • Where is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) headquartered?

    Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is headquartered in San Francisco, CA.

  • What industry is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) in?

    Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s primary industry is Buildings and Property.

  • Is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) a private or public company?

    Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is a Private company.

  • What is the current valuation of Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)?

    The current valuation of Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is .

  • What is Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s current revenue?

    The current revenue for Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US) is .

  • Who are Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US)’s investors?

    HCRx has invested in Nektar Therapeutics (Movantik, Adynovate and Rebinyn Royalties in the US).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process